Plasma miR-151-3p as a candidate diagnostic biomarker for head and neck cancer: a cross-sectional study within the INHANCE consortium

Roberta Pastorino, Michele Sassano, Francesco Danilo Tiziano, Luca Giraldi, Rosarita Amore, Dario Arzani, Emanuela Abiusi, Wolfgang Ahrens, Laia Alemany Vilches, Cristina Canova, Claire Mary Healy, Ivana Holcatova, Pagona Lagiou, Jerry Polesel, Maja Popovic, Ståle Nygård, Gabriella Cadoni, Ariana Znaor, Paolo Boffetta, Keitaro MatsuoIsao Oze, Paul Brennan, Stefania Boccia

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Identification of screening tests for the detection of head and neck cancer at an early stage is an important strategy to improving prognosis. Our objective was to identify plasma circulating microRNAs for the diagnosis of head and neck cancer (oral and laryngeal subsites), within a multicenter International Head and Neck Cancer Epidemiology (INHANCE) consortium.
Lingua originaleEnglish
pagine (da-a)1-7
Numero di pagine7
RivistaCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Volume2022
DOI
Stato di pubblicazionePubblicato - 2022

Keywords

  • head and neck

Fingerprint

Entra nei temi di ricerca di 'Plasma miR-151-3p as a candidate diagnostic biomarker for head and neck cancer: a cross-sectional study within the INHANCE consortium'. Insieme formano una fingerprint unica.

Cita questo